Procaps S.A. has completed a private placement of senior notes
Procaps S.A. has raised funds to refinance existing debt with new institutional investors.
Procaps is a leading integrated international healthcare and pharmaceutical company that develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps has a product reach in 50 markets and has strategically positioned itself to achieve its M&A initiative and expand new product categories in the B2B and B2C segments.
Oaklins’ team in Chile acted as the sole financial advisor to Procaps S.A. in the private placement of senior unsecured fixed-rate notes for an aggregate principal amount of US$115 million.


Talk to the deal team


Related deals
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.
Learn moreDolmen Engineering has been acquired by NIRAS
The private shareholders of Dolmen Engineering have sold the company to NIRAS. The integration will enable the two companies to strengthen their positions within the European life science and food & beverage sectors and offer a fully integrated suite of services.
Learn moreInMedica has acquired J. Pauliuko šeimos klinika
InMedica, the largest Lithuanian network of medical clinics, has acquired J. Pauliuko šeimos klinika.
Learn more